| # | Drug | Count |
|---|---|---|
| 0 | MELPHALAN HYDROCHLORIDE | 9 |
| 1 | TOPOTECAN | 7 |
| 2 | CARBOPLATIN | 5 |
| 3 | ETOPOSIDE | 5 |
| 4 | ACETAZOLAMIDE | 2 |
| 5 | ACETAZOLAMIDE SODIUM | 2 |
| 6 | LATANOPROST | 2 |
| 7 | RANIBIZUMAB | 2 |
| 8 | TIMOLOL | 2 |
| 9 | ALLOPURINOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPOTECAN | 7 | 0.0011 |
| 1 | MELPHALAN HYDROCHLORIDE | 9 | 0.0004 |
| 2 | TAFLUPROST | 1 | 0.0003 |
| 3 | ACETAZOLAMIDE SODIUM | 2 | 0.0003 |
| 4 | GLATIRAMER ACETATE INJECTION | 1 | 0.0002 |
| 5 | TIMOLOL | 2 | 0.0002 |
| 6 | TIMOLOL MALEATE OPHTHALMIC | 1 | 0.0001 |
| 7 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | 1 | 0.0001 |
| 8 | BRINZOLAMIDE | 1 | 0.0001 |
| 9 | TIMOLOL MALEATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 12 | 0.0002 |
| 1 | Carbonic Anhydrase Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Prostaglandin Analog [EPC] | 4 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 5 | Methylxanthine [EPC] | 1 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |